Recombinant Human TL-1A/TNFSF15 #abs00871

Recombinant Human TL-1A/TNFSF15 #abs00871

Please note that the price listed is only for your reference and may not be accurate. If you require more detailed pricing information, please be sure to contact our seller, Vecent. They will be able to provide you with the most up-to-date pricing information available. Thank you for your...

Description

Catalog-specification

Delivery time

USD price

abs00871-5ug

1-2 Weeks

138

abs00871-20ug

1-2 Weeks

344

abs00871-1mg

1-2 Weeks

3891

Please note that the price listed is only for your reference and may not be accurate. If you require more detailed pricing information, please be sure to contact our seller, Vecent. They will be able to provide you with the most up-to-date pricing information available. Thank you for your understanding.


Overview

Source

Escherichia coli.

Format

The concentrated solution in PBS, pH 7.4, with 0.02% Tween-20 was filtered through a 0.2 μm filter and then lyophilized.

Properties

aa_sequence

YTTFRVPPHA GASPILRVQD YSLRPDLVTA SPHHFKTVQT SHYTLAWEPN HFENRLTAKG LYTFKLYMNN FPSFYSYGID SFMTEGRTQC PARGAIQRES SDIVKIPTDV VEPSYKDTQT LGKSVMTLCM FWPQWNGEVS QLASLQGMAF QLKLSDVNKE KFGLMAFTD

Concentration

> 97 % by SDS-PAGE and HPLC analyses.

Endotoxin_level

The LAL method determined that the Recombinant Human TL-1A/TNFSF15 contains less than 0.1 EU/μg.

Activity

The standard and the sample under evaluation have comparable biological activity. The sample has been tested and found to be fully active when compared to the established standard.50The specific activity of a certain substance in inducing apoptosis has been found to be greater than 5.0 × 10, with a concentration that is less than 20 ng/ml based on its effect on human TF-1 cells. This information is critical in further understanding the potential applications of the substance in medical research and therapy.4 IU/mg.

Reconstitution

To ensure proper mixing, we suggest briefly centrifuging the vial before opening it so that the contents settle at the bottom. Reconstitute the vial by adding sterile distilled water or an aqueous buffer that contains 0.1% BSA, aiming for a concentration of 0.1-1.0 mg/ml. It is recommended to divide the reconstituted solution into smaller working aliquots and store them at a temperature of equal to or below -20 °C. If further dilutions are required, use suitable buffered solutions.

Stability & Storage

The lyophilized form of this preparation can be stored at 2-8 °C, but for long term storage, it's advisable to keep it at -20 °C, and preferably in a desiccated state. Once reconstituted, the preparation is stable for up to seven days at 2-8 °C. However, to maximize its stability, the reconstituted preparation should be divided into working aliquots and stored at temperatures ranging from -20 °C to -70 °C. Additionally, it's essential to avoid exposing the preparation to repeated freeze/thaw cycles.

Target

Accession

O95150

Gene IDs

9966


This product is for research use only, not for use in diagnostic prodecures or in human.


Hot Tags: recombinant human tl-1a/tnfsf15 #abs00871, China recombinant human tl-1a/tnfsf15 #abs00871 suppliers

You Might Also Like

Shopping Bags